EU-Japan Biotech & Pharma Partnering Conference 2026

16 Sept – 5 Oct 2026 | Osaka, Japan

ServiceUpdated on 26 August 2026

BiosimX CSP Modular Suite

About

BiosimX is a suite of crystal structure prediction services that makes CSP accessible to every lab. Its flexible, gated approach allows you to tailor the level of analysis to your development phase, budget, and timeline—starting as early as candidate selection and expanding as your molecule progresses.

Build your dataset coverage incrementally as you go, gaining increasingly actionable insights at each stage. Start with competing form risk assessment to identify potential solid-form risks early, then progress to preferred form accessibility and stability, and ultimately to deeper form analysis supporting manufacturing and IP strategies.

Designed to integrate seamlessly into your CMC workflow, BiosimX can be combined with experimental results generated by your team or partners at key intervals. Integrating these experimental insights with the in-silico analysis helps continuously refine your understanding of the solid-form landscape and make smarter, more informed decisions throughout your development pathway.

Type

  • Development

Attached files